Navigation Links
Aspirin Resistance Is Higher in Diabetics

Aspirin has long been the industry standard for the prevention and treatment of heart attacks.// However, for the more than 20 million Americans living with diabetes, the standard dose of aspirin might not provide adequate protection against future heart attacks. Researchers have recently demonstrated that aspirin resistance is higher in diabetics with coronary artery disease (CAD) than in non-diabetics at the standard 81mg dose of aspirin.

Most CAD deaths are caused by platelets sticking together and forming blood clots (thrombosis) that block blood flow within arteries, resulting in a heart attack. Aspirin inhibits clotting by specifically blocking an important enzyme, COX-1, which keeps platelets from sticking together. However, some diabetic patients may require a higher aspirin dose to achieve sufficient COX-1 blockade.

“The occurrence of clotting in patients on aspirin therapy is of major interest within the cardiovascular community. The effect of aspirin dosing in diabetic patients on the prevalence of aspirin resistance remains unclear,” said Paul A. Gurbel, M.D., director of the Center for Thrombosis Research at Sinai Hospital of Baltimore and lead author on this study. “Our data suggest that there may be a higher risk of thrombosis in diabetic patients during low dose aspirin therapy.”

The team at the Sinai Center for Thrombosis Research studied 120 aspirin treated patients (30 patients with diabetes) with stable coronary artery disease. Participants were randomly assigned to receive 81mg, 162mg, or 325mg of aspirin daily for four weeks each, for a total of 12 weeks. The response to aspirin was then tested by multiple laboratory methods. It was found that diabetic patients exhibited a higher prevalence of aspirin resistance than non-diabetic patients with 81mg of aspirin.

“The results of our findings may help to determine the best aspirin dose for diabetic patients, moving physicians away from the one-si
'"/>




Page: 1 2

Related medicine news :

1. What happens when Asthmatics consume Aspirin?
2. Aspirin reduces deaths
3. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
4. Aspirin - a drug after one’s own hear
5. Aspirin deflated
6. Aspirin surpasses Modern Anti-clotting Drugs
7. Night Time Aspirin Regimen Found to Reduce Blood Pressure
8. Aspirin Lowers Leukemia Risk
9. Aspirin usage linked with pancreatic cancer
10. Aspirin Found To Reduce The Risk Of Colon Cancer
11. Aspirin Induced Asthma , A Little-Known Inducer
Post Your Comments:
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Sickle cell ... red blood cells, is one of the most ... around the world, including more than 70,000 Americans.(1) ... of the American Society of Hematology highlights intriguing ... pandemic presents for children with this blood disorder, ...
(Date:12/6/2009)... Belluck of Belluck & Fox, LLP says dangerous substances such as ... , ... New York, NY (PRWEB) December 6, 2009 -- ... should be alert to reports of recalls due to lead paint ... ,“Close to 230,000 children visit hospital emergency rooms each year due ...
(Date:12/5/2009)... of Blood Cancer Is Most Challenging-- ,, ... have identified specific genes, dubbed partner genes, that fuse ... leukemia in infants. By more accurately defining specific partner ... benefit from particular treatments. ,, Oncologists also aim ...
(Date:12/5/2009)... innovative new international private medical insurance plan which follows the acclaimed ... the flexibility to add or remove a wide range of options ... tailor their benefits to complement those already offered in their country ... ...
(Date:12/4/2009)... 4 Thousands of KPMG LLP employees came together in ... community service event which combines the audit, tax and advisory ... national service day reflects our firm,s long history of volunteerism. ... of caring to brighten the holidays for some children," said ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2
... drive, Chinese authorities have bought 305 million condoms for ... ,This is the first time the government purchased condoms ... the health authorities said on Thursday. ,The ... Control (CDC) across the country., ,The government signed ...
... obstetricians urge their pregnant patients to exercise regularly, when ... ,The researcher from Saint Louis University School of ... September issue of a publication for obstetricians and gynecologists. ... exercise in women with healthy pregnancies results in no ...
... Recent research has shown that marital problems affect men and ... relationship affects the wife more than the husband. Furthermore, spouses ... health problems. ,This finding could mean that couples face ... results indicate that in addition to the carryover of work ...
... Laboratories shares fell by 1.3% to close at $43.80 following ... drug Xinlay. Increased number of scientists and analysts question the ... its drug. ,The drug that is to be ... Phase III trial leading to disapproval of the drug by ...
... human organs and tissues has captured the imagination of ... transplantation performed between identical // twins by Joseph Murray ... might even be possible to transplant non-human tissues from ... now. This process of transplanting organs and tissues and ...
... Women who take oral contraceptives may be less at ... This study result was published in the recent issue ... delayed the onset // and eased the course of ... which contain estrogen, and pregnancy and the postpartum period ...
Other Medicine News:Health News:China To Distribute Free Condoms To Combat AIDS/HIV 2Health News:Abbott’s Laboratories R&D Capabilities Questione 2Health News:Kidneys Can Be Transplanted From Animals Such As Pigs In Future 2
(Date:12/4/2009)... HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers ... an acceleration device to enhance orthodontics, announced the ... by PennWell Corporation , a leader in ... dentistry. The course focuses on patient views ...
(Date:12/4/2009)... AstraZeneca (NYSE: AZN ) today announced ... approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets ... Major Depressive Disorder (MDD). SEROQUEL XR is the only ... treat both major depressive disorder as adjunctive therapy and ...
(Date:12/3/2009)... genetic variation that may indicate a patient,s risk of ... certain pharmaceutical therapies or chemicals is one of several ... (NYSE: DGX ) will present during the ... Exposition, December 5-8, 2009, in New Orleans, LA. ...
Breaking Medicine Technology:AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York 5748 1National Pharmacy Technician Day 3A Pharmacy Technician Certification Board 28PTCB 29 Recognizes Pharmacy Technicians During Octobers American Pharma 5744 1National Pharmacy Technician Day 3A Pharmacy Technician Certification Board 28PTCB 29 Recognizes Pharmacy Technicians During Octobers American Pharma 5744 2Caraco Pharmaceutical Laboratories Ltd Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 5740 1Caraco Pharmaceutical Laboratories Ltd Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 5740 2Caraco Pharmaceutical Laboratories Ltd Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 5740 3Caraco Pharmaceutical Laboratories Ltd Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 5740 4Caraco Pharmaceutical Laboratories Ltd Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 5740 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 5740 6Caraco Pharmaceutical Laboratories Ltd Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 5740 7
... acute lymphoblastic,leukemia combined with molecular science could help ... MEMPHIS, Tenn., March 20 The dramatic,increase that ... with acute,lymphoblastic leukemia (ALL) will be difficult to ... to an article,by St. Jude Children,s Research Hospital ...
... Mexico, March 20 Optimum Health Regeneration,Center announced ... for,pain management and impaired mobility. This New Mexico ... recorded significant improvements in reduced pain,increased physical mobility ... with umbilical cord stem cells and ozone therapy ...
Other Medicine Technology:Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers 2Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico 2
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C...
... The neonate/pediatric blanket provides warmth ... children. The blanket may be ... comes with a drape that ... the patient to help retain ...
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
This blanket gently surrounds the child with temperature-controlled air. Use one or both of the enclosed clear plastic drapes to keep warmed air near the skin....
Medicine Products: